+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Global Periodontal Therapeutics Market to 2027

  • ID: 5561443
  • Report
  • February 2022
  • Region: Global
  • 155 Pages
  • Qualiket Research

FEATURED COMPANIES

  • 3M Company
  • Den-Mat Holdings LLC
  • Dexcel Pharma
  • Eli Lilly and Company
  • Galderma S.A.
Periodontal Therapeutics is used for treatment of periodontal disease. It is chronic bacterial infection caused due to microbial plaque often called as gum disease, which is colonized on tooth surface and below the gingival margin. Hormonal changes, poor oral health hygiene, smoking, and some hereditary factors are the causes of periodontal disease.



Market Drivers


Increase in geriatric population is the key driving factor which is expected to boost the global periodontal therapeutics market growth. Furthermore, increase in prevalence of periodontal diseases due to changing lifestyle will have the positive impact on growth of global periodontal therapeutics market. Moreover, rise in tooth retention which leads peritonitis which is expected to fuel the periodontal therapeutics industry growth during this forecast period. Also, continuous advancements in treatment with the help of novel drug and rise in preference to local drug for treatment of periodontal disease which is expected to propel the growth of global periodontal therapeutics market.

Market Restraints


However, lack of awareness regarding oral hygiene among people is the restraining factor which is expected to hamper the global periodontal therapeutics market growth.

Market Segmentation


Global Periodontal Therapeutics Market is segmented into type such as Necrotizing periodontal disease, Aggressive periodontitis, Chronic periodontitis, and Gingivitis, by treatment such as Local Antibiotics, Systematic Antibiotics, and Others. Further, Global Periodontal Therapeutics Market is segmented into end users such as Hospital, and Dental Clinic.

Also, Global Periodontal Therapeutics Market is segmented into five regions such as North America, Latin America, Europe, Asia Pacific, and Middle East & Africa.

Market Key Players


Various key players are discussed in this report such as Galderma S.A., Dexcel Pharma, Den-Mat Holdings, LLC, Kaken Pharmaceuticals Co. Ltd, Valeant Pharmaceuticals, Inc, 3M Company, and Eli Lilly and Company

Market Taxonomy


By Type

  • Necrotizing periodontal disease
  • Aggressive periodontitis
  • Chronic periodontitis
  • Gingivitis

By Treatment

  • Local Antibiotics
  • Systematic Antibiotics
  • Others

By End User

  • Hospital
  • Dental Clinic

By Region

  • North America
  • Latin America
  • Europe
  • Asia Pacific
  • Middle East & Africa
Frequently Asked Questions about the Global Periodontal Therapeutics Market

What is the estimated value of the Global Periodontal Therapeutics Market?

The Global Periodontal Therapeutics Market was estimated to be valued at $356.0 Million in 2020.

What is the growth rate of the Global Periodontal Therapeutics Market?

The growth rate of the Global Periodontal Therapeutics Market is 9.2%, with an estimated value of $680.2 Million by 2027.

What is the forecasted size of the Global Periodontal Therapeutics Market?

The Global Periodontal Therapeutics Market is estimated to be worth $680.2 Million by 2027.

Who are the key companies in the Global Periodontal Therapeutics Market?

Key companies in the Global Periodontal Therapeutics Market include Galderma S.A., Dexcel Pharma, Den, Mat Holdings LLC, Kaken Pharmaceuticals Co. Ltd, Valeant Pharmaceuticals Inc and Eli Lilly and Company.
Note: Product cover images may vary from those shown

FEATURED COMPANIES

  • 3M Company
  • Den-Mat Holdings LLC
  • Dexcel Pharma
  • Eli Lilly and Company
  • Galderma S.A.

1 Introduction
1.1 Objective of the Study
1.2 Market definition
1.3 Market Scope
2 Research Methodology
2.1 Data Mining
2.2 Validation
2.3 Primary Interviews
2.4 List of Data Sources
3 Executive Summary
4 Global Periodontal Therapeutics Market Outlook
4.1 Overview
4.2 Market Dynamics
4.2.1 Drivers
4.2.2 Restraints
4.2.3 Opportunities
4.3 Porters Five Force Model
4.4 Value Chain Analysis
5 Global Periodontal Therapeutics Market, By Type
5.1 Y-o-Y Growth Comparison, By Type
5.2 Global Periodontal Therapeutics Market Share Analysis, By Type
5.3 Global Periodontal Therapeutics Market Size and Forecast, By Type
5.3.1 Necrotizing periodontal Disease
5.3.2 Aggressive periodontal
5.3.3 Chronic periodontitis
5.3.4 Gingivitis
6 Global Periodontal Therapeutics Market, By Treatment
6.1 Y-o-Y Growth Comparison, By Treatment
6.2 Global Periodontal Therapeutics Market Share Analysis, By Treatment
6.3 Global Periodontal Therapeutics Market Size and Forecast, By Treatment
6.3.1 Local Antibiotic
6.3.2 Systematic Antibiotic
6.3.3 Others
7 Global Periodontal Therapeutics Market, By End User
7.1 Y-o-Y Growth Comparison, By End User
7.2 Global Periodontal Therapeutics Market Share Analysis, By End User
7.3 Global Periodontal Therapeutics Market Size and Forecast, By End User
7.3.1 Hospital
7.3.2 Dental Clinic
8 Global Periodontal Therapeutics Market, By Region
8.1 Global Periodontal Therapeutics Market Share Analysis, By Region
8.2 Global Periodontal Therapeutics Market Share Analysis, By Region
8.3 Global Periodontal Therapeutics Market Size and Forecast, By Region
9 North America Periodontal Therapeutics Market Analysis and Forecast (2017 - 2027)
9.1 Introduction
9.2 North America Periodontal Therapeutics Market Share Analysis, By Type
9.3 North America Periodontal Therapeutics Market Size and Forecast, By Treatment
9.4 North America Periodontal Therapeutics Market Size and Forecast, By End User
9.5 North America Periodontal Therapeutics Market Size and Forecast, By Country
9.5.1 U.S.
9.5.2 Canada
9.5.3 Mexico
10 Europe Periodontal Therapeutics Market Analysis and Forecast (2017 - 2027)
10.1 Introduction
10.2 Europe Periodontal Therapeutics Market Share Analysis, By Type
10.3 Europe Periodontal Therapeutics Market Size and Forecast, By Treatment
10.4 Europe Periodontal Therapeutics Market Size and Forecast, By End User
10.5 Europe Periodontal Therapeutics Market Size and Forecast, By Country
10.5.1 Germany
10.5.2 France
10.5.3 UK
10.5.4. Rest of Europe
11 Asia Pacific Periodontal Therapeutics Market Analysis and Forecast (2017 - 2027)
11.1 Introduction
11.2 Asia Pacific Periodontal Therapeutics Market Share Analysis, By Type
11.3 Asia Pacific Periodontal Therapeutics Market Size and Forecast, By Treatment
11.4 Asia Pacific Periodontal Therapeutics Market Size and Forecast, By End User
11.5 Asia Pacific Periodontal Therapeutics Market Size and Forecast, By Country
11.5.1 China
11.5.2 Japan
11.5.3 India
11.5.4. Rest of Asia Pacific
12 Latin America Periodontal Therapeutics Market Analysis and Forecast (2017 - 2027)
12.1 Introduction
12.2 Latin America Periodontal Therapeutics Market Share Analysis, By Type
12.3 Latin America Periodontal Therapeutics Market Size and Forecast, By Treatment
12.4 Latin America Periodontal Therapeutics Market Size and Forecast, By End User
12.5 Latin America Periodontal Therapeutics Market Size and Forecast, Country
13 Middle East Periodontal Therapeutics Market Analysis and Forecast (2017 - 2027)
13.1 Introduction
13.2 Middle East Periodontal Therapeutics Market Share Analysis, By Type
13.3 Middle East Periodontal Therapeutics Market Size and Forecast, By Treatment
13.4 Middle East Periodontal Therapeutics Market Size and Forecast, By End User
13.5 Middle East Periodontal Therapeutics Market Size and Forecast, By Country
14 Competitive Analysis
14.1 Competition Dashboard
14.2 Market share Analysis of Top Vendors
14.3 Key Development Strategies
15 Company Profiles
15.1 Galderma S.A
15.1.1 Overview
15.1.2 Offerings
15.1.3 Key Financials
15.1.4 Business Segment & Geographic Overview
15.1.5 Key Market Developments
15.1.6 Key Strategies
15.2 Dexcel Pharma
15.2.1 Overview
15.2.2 Offerings
15.2.3 Key Financials
15.2.4 Business Segment & Geographic Overview
15.2.5 Key Market Developments
15.2.6 Key Strategies
15.3 Den-Mat Holdings, LLC
15.3.1 Overview
15.3.2 Offerings
15.3.3 Key Financials
15.3.4 Business Segment & Geographic Overview
15.3.5 Key Market Developments
15.3.6 Key Strategies
15.4 Kaken Pharmaceuticals Co. Ltd
15.4.1 Overview
15.4.2 Offerings
15.4.3 Key Financials
15.4.4 Business Segment & Geographic Overview
15.4.5 Key Market Developments
15.4.6 Key Strategies
15.5 Valeant Pharmaceuticals, Inc
15.5.1 Overview
15.5.2 Offerings
15.5.3 Key Financials
15.5.4 Business Segment & Geographic Overview
15.5.5 Key Market Developments
15.5.6 Key Strategies
15.6 3 M Company,
15.6.1 Overview
15.6.2 Offerings
15.6.3 Key Financials
15.6.4 Business Segment & Geographic Overview
15.6.5 Key Market Developments
15.6.6 Key Strategies
15.7 Eli Lilly and Company
15.7.1 Overview
15.7.2 Offerings
15.7.3 Key Financials
15.7.4 Business Segment & Geographic Overview
15.7.5 Key Market Developments
15.7.6 Key Strategies
Note: Product cover images may vary from those shown

A selection of companies mentioned in this report includes:

  • Galderma S.A.
  • Dexcel Pharma
  • Den-Mat Holdings LLC
  • Kaken Pharmaceuticals Co. Ltd
  • Valeant Pharmaceuticals Inc
  • 3M Company
  • Eli Lilly and Company
Note: Product cover images may vary from those shown